CRP and myocardial infarction: Specifically, the rat CRP-specific ASO achieved a >60% reduction of rat blood CRP levels and improved their heart function and pathology following MI, and treating human CRP transgenic mice with a human CRP-specific ASO reduced blood human CRP by >70%.